Anna Agnese Stanziola
Biographic Data
| ID | 7864758 |
|---|---|
| NAME | Anna Agnese Stanziola |
| GIVEN NAMES | Anna Agnese |
| FAMILY NAME | Stanziola |
| SIGNATURE | STANZIOLA A A |
| AFFILIATIONS | Ospedale Monaldi |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
No prominent works on this page.
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
Atypical pneumonia (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Dermatological and COVID-19 studies (1 work) · Disease (1 work) · Gastroenterology (1 work) · Immunology (1 work) · Inhalation and Respiratory Drug Delivery (1 work) · Internal Medicine (1 work) · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 work) · Medicine (1 work)